Evidence map›Paper›PMID 23878212›Full record

Trial reportProceedings of the National Academy of Sciences of the United States of America2013

Advertisements impact the physiological efficacy of a branded drug.

Emir Kamenica, Robert Naclerio, Anup Malani

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. The role of patient beliefs in open-label placebo effects.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2019
    Article
  3. Article
  4. Harnessing the placebo effect: Exploring the influence of physician characteristics on placebo response.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2017
    Article
  5. The Signaling Theory of Symptoms : An Evolutionary Explanation of the Placebo Effect.Evolutionary psychology : an international journal of evolutionary approaches to psychology and behavior · 2015
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emir KamenicaBooth School of Business, University of Chicago, Chicago, IL 60637, USA. emir@uchicago.edu
Robert Naclerio
Anup Malani

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted randomized clinical trials to examine the impact of direct-to-consumer advertisements on the efficacy of a branded drug. We compared the objectively measured, physiological effect of Claritin (Merck & Co.), a leading antihistamine medication, across subjects randomized to watch a movie spliced with advertisements for Claritin or advertisements for Zyrtec (McNeil), a competitor antihistamine. Among subjects who test negative for common allergies, exposure to Claritin advertisements rather than Zyrtec advertisements increases the efficacy of Claritin. We conclude that branded drugs can interact with exposure to television advertisements.

Indexed as

TelevisionAdultAdvertisingCetirizineFemaleFollow-Up StudiesHistamine H1 Antagonists, Non-SedatingHumansHypersensitivityLoratadineMaleTime FactorsTreatment OutcomeCetirizineHistamine H1 Antagonists, Non-SedatingLoratadineadvertisingplacebo effect

Identifiers

PMID23878212
PMCPMC3740832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.